TVTX Form 144: 32,750 Shares via Option Exercise

TVTX submitted a Form 144 notice reporting the proposed sale of 32,750 common shares via a stock option exercise on 04/14/2026, with cash as the payment method.

Accepted by SEC EDGAR 04/14/2026 - 04:09 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

TVTX submitted a Form 144 notice reporting the proposed sale of 32,750 common shares via a stock option exercise on 04/14/2026, with cash as the payment method. The filing also records a prior sale of 10,000 common shares by Roy Baynes on 04/06/2026 for $330,000.

Key Figures

Proposed shares to be sold: 32,750 shares Associated numeric entry: 1,352,130.00 Context value: 92,241,550 +3 more

6 metrics

Proposed shares to be sold 32,750 shares stock option exercise on 04/14/2026

Associated numeric entry 1,352,130.00 numeric field listed in securities information

Context value 92,241,550 numeric field listed in securities information

Prior sale - shares 10,000 shares sold by Roy Baynes on 04/06/2026

Prior sale - proceeds $330,000 proceeds from Roy Baynes sale on 04/06/2026

Filing date 04/14/2026 date associated with proposed stock option exercise

Key Terms

Stock Option Exercise, Issuer, Securities To Be Sold

3 terms

Stock Option Exercise financial

"Common | 04/14/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Issuer regulatory

"Stock Option Exercise | Issuer | | | 32750"

Securities To Be Sold regulatory

"144: Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does TVTX's Form 144 report?

The Form 144 reports a proposed sale of 32,750 common shares by means of a stock option exercise on 04/14/2026. It also notes a sale of 10,000 shares on 04/06/2026 for $330,000.

Who is listed as having sold shares recently in the TVTX filing?

Roy Baynes is listed as selling 10,000 common shares on 04/06/2026 for $330,000. The Form 144 also shows a separate proposed sale of 32,750 shares via option exercise.

What method of payment is shown for the 32,750-share transaction?

The filing indicates the stock option exercise was settled in cash on 04/14/2026. No other proceeds uses or recipients are described in the excerpt.

Which broker or intermediary is named in the Form 144?

Morgan Stanley Smith Barney LLC Executive Financial Services (1 New York Plaza, New York) is listed in the securities information section of the filing associated with the proposed sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001680739
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TRAVERE THERAPEUTICS, INC.
SEC File Number	001-36257
Address of Issuer	3611 Valley Centre Drive Suite 300 San Diego CALIFORNIA 92130
Phone	888-969-7879
Name of Person for Whose Account the Securities are To Be Sold	ROY BAYNES
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	32750	1352130.00	92241550	04/14/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/14/2026	Stock Option Exercise	Issuer			32750	04/14/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ROY BAYNES 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	04/06/2026	10000	330000.00

144: Remarks and Signature

Remarks
Date of Notice	04/14/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/17/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Roy Dennis Baynes
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)